Delivery Order SPE2DB22D3501-SPE2DB25FVY84

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,376.10, to provide the product "Testosterone 1% (25mg/2.5g) PK 2.5gm". The contract has a completion date of June 9, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,706.76, is a delivery order for the supply of Testosterone 1% (25mg/2.5g) in a 2.5g package. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $6,894.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "TESTOSTERONE 1.62% (2.5 G) PKT UD 2.5GM" pharmaceutical products. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 24, 2024. This contract award is associated with a larger Indefinite...
This federal contract award, with a value of $1,416.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation. The contract covers the delivery of TESTOSTERONE CYP 200 MG/MLML, a pharmaceutical product, with a period of performance through January 31, 2025. Amerisourcebergen holds a...
This federal contract award, valued at $2,132.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Testosterone 1% (25mg/2.5g) pharmaceutical products. It is a firm fixed-price delivery order contract with a completion date of February 10, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $1,530.80, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Testosterone 1% (25mg/2.5g) pharmaceutical product, with a completion date of October 25, 2024. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,944.00, for the supply of "TESTOSTERONE 1% (25MG/2.5G) PK 2.5GM" pharmaceutical products. The contract is not designated as a Set-Aside and has an Ultimate Completion Date of June...
This federal contract award, valued at $1,248.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of testosterone 1% (50 mg/5 g) pharmaceutical product, with an ultimate completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award, valued at $2,282.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Testosterone 1% (25mg/2.5g) pharmaceutical products. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. The contract is likely...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,207.39 Firm Fixed Price Delivery Order is for the supply of "TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM," a medical product. The award has an ultimate completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVY84
    Delivery Order

This federal contract award is a Delivery Order valued at $1,944.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TESTOSTERONE 1% (25MG/2.5G) PK 2.5GM, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/8/25, 9:51 AM